Ameriprise’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Sell |
3,364
-47
| -1% | -$4.13K | ﹤0.01% | 3670 |
|
|
2025
Q1 | $311K | Sell |
3,411
-19,628
| -85% | -$1.79M | ﹤0.01% | 3632 |
|
|
2024
Q4 | $1.99M | Sell |
23,039
-3,806
| -14% | -$328K | ﹤0.01% | 2914 |
|
|
2024
Q3 | $2.55M | Buy |
26,845
+2,446
| +10% | +$232K | ﹤0.01% | 2775 |
|
|
2024
Q2 | $2.23M | Sell |
24,399
-6,729
| -22% | -$616K | ﹤0.01% | 2813 |
|
|
2024
Q1 | $2.83M | Buy |
31,128
+6,705
| +27% | +$609K | ﹤0.01% | 2694 |
|
|
2023
Q4 | $1.99M | Sell |
24,423
-11,852
| -33% | -$964K | ﹤0.01% | 2876 |
|
|
2023
Q3 | $2.9M | Buy |
36,275
+23,812
| +191% | +$1.9M | ﹤0.01% | 2641 |
|
|
2023
Q2 | $982K | Sell |
12,463
-1,435
| -10% | -$113K | ﹤0.01% | 3181 |
|
|
2023
Q1 | $1.08M | Buy |
+13,898
| New | +$1.08M | ﹤0.01% | 3112 |
|
|
2017
Q4 | – | Sell |
-4,567
| Closed | -$264K | – | 3707 |
|
|
2017
Q3 | $264K | Sell |
4,567
-4,304
| -49% | -$249K | ﹤0.01% | 3426 |
|
|
2017
Q2 | $524K | Buy |
8,871
+107
| +1% | +$6.32K | ﹤0.01% | 3213 |
|
|
2017
Q1 | $483K | Buy |
8,764
+928
| +12% | +$51.1K | ﹤0.01% | 3178 |
|
|
2016
Q4 | $411K | Buy |
+7,836
| New | +$411K | ﹤0.01% | 3354 |
|
|
2016
Q2 | – | Sell |
-5,940
| Closed | -$342K | – | 3808 |
|
|
2016
Q1 | $342K | Buy |
5,940
+1,906
| +47% | +$110K | ﹤0.01% | 3300 |
|
|
2015
Q4 | $263K | Buy |
+4,034
| New | +$263K | ﹤0.01% | 3531 |
|
|
2014
Q2 | – | Sell |
-100
| Closed | -$6K | – | 5610 |
|
|
2014
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 4716 |
|
|
2013
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 4612 |
|
|
2013
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 5228 |
|
|
2013
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 5121 |
|